Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $.001 Par Value
-
Shares outstanding
-
20.7M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
6.98M
-
Shares change
-
-390K
-
Total reported value, excl. options
-
$17.6M
-
Value change
-
-$1.2M
-
Put/Call ratio
-
2.44
-
Number of buys
-
19
-
Number of sells
-
-32
-
Price
-
$2.51
Significant Holders of PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) as of Q3 2025
73 filings reported holding PETS - PETMED EXPRESS INC - Common Stock, $.001 Par Value as of Q3 2025.
PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.98M shares
of 20.7M outstanding shares and own 33.69% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (1.27M shares), VANGUARD GROUP INC (964K shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (788K shares), BlackRock, Inc. (543K shares), FEDERATED HERMES, INC. (482K shares), DIMENSIONAL FUND ADVISORS LP (482K shares), OAKTOP CAPITAL MANAGEMENT II, L.P. (436K shares), GEODE CAPITAL MANAGEMENT, LLC (203K shares), CITADEL ADVISORS LLC (182K shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (175K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.